WNV surveillance and prevention of transfusion transmission in Italy

Similar documents
WNV, Italian approach. Simonetta Pupella

Ministry of Health DEPARTMENT FOR ANIMAL PUBLIC HEALTH, NUTRITION AND FOOD SAFETY WEST NILE DISEASE EPIDEMIOLOGICAL SITUATION IN ITALY

UNDERSTANDING THE ENVIRONMENTAL DRIVERS INFLUENCING THE EPIDEMIOLOGICAL RISK OF VECTOR BORNE DISEASES

Integrated surveillance of vector borne diseases The example of WNV surveillance in Italy

West Nile Virus Surveillance Report, 2018: For week ending July 7

West Nile Virus Surveillance Report, 2018: June 23

Outbreak of West Nile Virus in Southern France in 2003

THREAT OF WEST NILE VIRUS IN THE IBERIAN PENINSULA SPAIN S. Oyonarte MD PhD (CCST) ISBT LISBON 2011

ORIGINAL ARTICLE. Keywords: WNV, RNA, EQAP, NAT, plasma. Blood Transfus 2012; 10: DOI / SIMTI Servizi Srl

WEST NILE VIRUS SURVEILLANCE IN MADISON AND DANE COUNTY

West Nile Virus Surveillance Report, 2017: August 19

West Nile Virus Surveillance Report, 2017: September 2

Climate changes and animal infectious diseases

WEST NILE FEVER in Greece Epidemiological Situation in 2011

Arbovirus Surveillance in Massachusetts 2016 Massachusetts Department of Public Health (MDPH) Arbovirus Surveillance Program

Massachusetts Arbovirus Surveillance and Response Plan

West Nile Virus in Maricopa County

MINISTERIO DE MEDIO AMBIENTE Y MEDIO RURAL Y MARINO WEST NILE CURRENT SITUATION, NATIONAL SURVEILLANCE PROGRAM AND FUTURE OF THE DISEASE IN SPAIN

Evaluation of the West Nile Surveillance System for the State of Kansas

Alberta s Response Plan (2005)

Manitoba Weekly West Nile virus Surveillance Report

West Nile Virus in Maricopa County

Mosquitoborne Viral Diseases

West Nile Virus in Maricopa County

Worked out examples of outbreak scenarios

Weekly Epidemiological Report for West Nile Virus disease, Greece, July

June 8, Division of Dockets Management (HFA 305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

West Nile Virus in Maricopa County

ARBOVIRAL RISKS TO BLOOD SAFETY IN AUSTRALIA. Clive Seed Australian Red Cross Blood Service ISBT TTD-WP meeting 26 June, 2015

16 th JPC REM ESA M ohammedia 18-19th April Surveillance of low pathogenic Avian Influenza virus

H5N8 HPAI in Italy in 2017 Epidemiological situation and eradication strategy. Dr. Sarah Guizzardi

(SCENIHR) Updated Opinion on. The Safety of Human Blood and Organs with Regard to West Nile Virus

West Nile Virus-Impact of the 2012 Epidemic in Texas

Human surveillance of TOSV neuroinvasive infections M.Paola Landini Unit of Clinical Microbiology - Regional Center for microbiological emergencies,

West Nile Virus. Family: Flaviviridae

Dallas County Health and Human Services Arbovirus Surveillance Report Week 39 ending September 29, 2018

Evidence Based Considerations for Adult Mosquito Control

How to design intranational deferral Malaria in Greece

WEST NILE VIRUS AND BLOOD SAFETY INTRODUCTION TO A PREPAREDNESS PLAN IN EUROPE

SHASTA COUNTY Health and Human Services Agency

Routine NAT-screening for West Nile Virus Infections in Germany: Being prepared

Arboviral Surveillance and Control Annual Report: Pennsylvania, 2014

West Nile Virus in the Region of Peel 2002

Thomas McGee, L.C. 920 Main Street, Suite 1700 Kansas City, MO (816) * Toll Free (800) WEST NILE VIRUS

West Nile virus and other arboviral activity -- United States, 2013 Provisional data reported to ArboNET Tuesday, July 23, 2013

Weekly Epidemiological Report for the West Nile virus disease, Greece, October 2013

WEST NILE VIRUS SUMMARY REPORT 2017 SEASON UTAH DEPARTMENT OF HEALTH

Outbreak of Chikungunya fever in the Province of Ravenna:

Clinical Information on West Nile Virus (WNV) Infection

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 34)

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

Il Patient Blood Management in Italia. Dr. Giancarlo Maria Liumbruno Direttore Generale, Centro Nazionale Sangue Istituto Superiore di Sanità, Roma

The Italian blood system: an overview with special focus on plasma production and plasma-derived medicinal products

NORTH SHORE MOSQUITO ABATEMENT DISTRICT 2018 Surveillance Summary

TREATING THE REHAB PATIENT WITH WEST NILE VIRUS. Amy J. Wilson MD Medical Director, Baylor Institution of Rehabilitation January 2014

Weekly Epidemiological Report for West Nile Virus disease, Greece, September

West Nile Virus. Lyle R. Petersen, M.D., M.P.H.

Odyssean malaria outbreak at a bush lodge in Madikwe Game Reserve, North West Province, October-November 2015

Mosquito Control Matters

Tarrant County Influenza Surveillance Weekly Report CDC Week 43: Oct 22-28, 2017

DENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo

HELLENIC CENTER FOR DISEASE CONTROL & PREVENTION (H.C.D.C.P) MINISTRY OF HEALTH & SOCIAL SOLIDARITY

Dengue Fever & Dengue Hemorrhagic Fever Annual Reports to WHO

West Nile Virus. By Frank Riusech

Preliminary Programme Be E.I.! 2013 Meeting of ECDC National Focal Points for Threat Detection

West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 11 to September 17, 2016 (Week 37)

Arbovirus Infections and the animal reservoir

West Nile virus and other arboviral activity -- United States, 2013 Provisional data reported to ArboNET Tuesday, January 7, 2014

Management of notifications of donors with Creutzfeldt-Jakob disease (post-donation information) SIMTI Servizi Srl

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 36)

West Nile virus and other arboviral activity -- United States, 2014 Provisional data reported to ArboNET Tuesday, September 2, 2014

Outbreak Investigation Guidance for Vectorborne Diseases

Transfusion transmitted infections in National Haemovigilance Systems: the Greek experience

Preparedness plan against Chikungunya and dengue dissemination in mainland France Public Health perspective

Donation Criteria for Men who have Sex with Men (MSM): Update from Canadian Blood Services

2017 SCAAP Summer Conference. Lilian Peake, MD, MPH

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 31)

Protecting You and Your Community from West Nile Virus. Eagle County Environmental Health Department

IPM & the West Nile Virus Epidemic, Greece, Terms to Know. Which is more dangerous? Florida and Thessaloniki, Greece

Pathogen Safety and BSE / variant CJD

Emerging TTIs How Singapore secure its blood supply

Tarrant County Influenza Surveillance Weekly Report CDC Week 40: Oct 2-8, 2016

West Nile Virus Surveillance and Management in Québec: a successful approach (so far )

West Nile Virus Update. April 15, 2014

WEST NILE VIRUS PLAN

Mosquito Threats in Burbank West Nile virus and Zika Update. Presented by Kelly Middleton, Director of Community Affairs

Tarrant County Influenza Surveillance Weekly Report CDC Week 17: April 22-28, 2018

West Nile Virus Activity in Harris County, Texas Rudy Bueno, Jr., Ph.D. Division Director, HCPHES Mosquito Control

West Nile Disease. World situation and impact on public health

Presentation of Istituto Superiore di Sanità, Rome, Italy

Guide on Access to the Yellow Fever ICG Stockpile. Emergency Campaigns. International Coordinating Group on Vaccine. Geneva, Switzerland 2012

Rome Date submitted to OIE 21/07/2017

Tarrant County Influenza Surveillance Weekly Report CDC Week 51: Dec 17-23, 2017

Update on Transfusion- Transmitted Infectious Diseases

Tarrant County Influenza Surveillance Weekly Report CDC Week 4: Jan 21-27, 2018

Emerging vector-borne diseases in the United States: What s next and are we prepared?

WEST NILE VIRUS AND OTHER MOSQUITO-BORNE DISEASE NATIONAL SURVEILLANCE REPORT

West Nile virus and other arboviral activity -- United States, 2016 Provisional data reported to ArboNET Tuesday, October 11, 2016

Epidemiological Profile of West Nile Virus in Kent County, Michigan

Transcription:

Ministero del Lavoro, della Salute e delle Politiche Sociali Istituto Superiore di Sanità Centro Nazionale Sangue Via Giano della Bella, 27 00162 Roma Tel: 06 4990 4953 / 4954 Fax: 06 4990 4975 E-mail: cns@iss.it WNV surveillance and prevention of transfusion transmission in Italy Communication to DG SANCO 11 th August 2009 - Concerning the local WNV epidemic outbreak occurred in 2008, we retrospectively estimated the risk of blood donations from viremic asymptomatic donors entering the blood stock. Applying the statistical model published by Biggerstaff & Petersen 1, based on the incidence of human neuroinvasive cases and their overall length, the average risk of blood donation by viremic asymptomatic donors was estimated at 2.2/10,000 donations. We also applied an internally generated statistical model 2 starting from seroprevalence in blood donors (according to a study carried out on 8,000 blood donors from the area of Ferrara in 2008-2009, seroprevalence was 0.77%). With this model the average estimated risk of blood donations by viremic asymptomatic donors was 3.6/10,000 donations. Hence, the overall average dimension of the risk in Summer-Autumn 2008 estimated by the Biggerstaff-Petersen model was confirmed starting from seroprevalence in blood donors. As previously reported 3, WNV NAT testing on blood donations in at risk areas was started end September and discontinued beginning of December, 2008. No NAT positive donors were detected, most probably because the probability to detect viremic asymptomatic donors is very significantly related to the peak of activity of vector insects, which in Italy occurs in midsummer. - Concerning the prevention of the transmission of WNV infection by transfusion in 2009, epidemiological surveillance in the at risk areas (provincial districts of Ferrara, Rovigo and Mantua) has been started since late Spring, by entomological and wild bird surveillance. Surveillance on horses is now less helpful, as most horses have been vaccinated. Active surveillance of human neuroinvasive WND has been restarted in the regions of Emilia Romagna (Ferrara), Veneto (Rovigo) and Lombardy (Mantua). For the prevention of the transmission of WNV infection by transfusion it was decided to adopt the same criteria adopted in 2008, i.e. temporary introduction of NAT testing in the pertinent at risk area and 28 day deferral of blood donors having been for at least one night in the same area, immediately after the notification of the first human neuroinvasive WND case. As previously reported 3, the introduction of NAT testing is justified by the fact that discontinuing blood donations in any Italian northern area - especially in the middle of Summer - would cause critical regional shortages in the blood supply and possibly significant national shortages, as several northern blood centres critically supply some southern regions year round. Furthermore, it was decided to experimentally introduce WNV NAT testing on all blood donations from donors resident in the provincial districts of Ferrara, Rovigo and Mantua and to serologically test a significant number of them, in the period 1 st Aug 30 th Oct. This decision was taken considering the 2008 estimates of the risk of collecting blood and blood components from viremic asymptomatic donors, the first 1 Biggerstaff BJ, Petersen RL. Estimated risk of transmission of West Nile Virus through blood transfusion in the US, 2002. Transfusion. 2003 Aug;43(8):1007-17 2 Pupella S, Panetta V, Grazzini G. Italian National Blood Centre and Biostatistics Unit, Research Foundation Fatebenefratelli Rome, Italy. 3 Grazzini G, Liumbruno GM, Pupella S, et Al. West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus. 2008 Oct;6(4):235-7. Pagina 1 di 4

results of entomological surveillance, and in order to obtain as much information as possible about this year s circulation of the virus in blood donors in at risk areas, in order to enhance decision making ability for next year(s). Following the introduction of NAT testing, it was also decided to consider the first WNV NAT positivity in an asymptomatic blood donor as a trigger to implement the 28 day deferral provision related to the involved provincial district, independent from the occurrence/notification of human neuroinvasive WND cases. All the above decisions were shared by the regional public health and blood authorities of Emilia Romagna, Veneto and Lombardy, the National Blood Centre and the Department of Prevention of the Ministry of Labour, Health and Social Policies. - On 4 th August the first WNV NAT positive blood donation from an asymptomatic donor resident in the area of Mantua was detected by the Blood Centre of Mantua. Following the confirmation and official notification of the above positivity, on 7 th August the Italian National Blood Centre indicated a 28 day deferral for all donors having been for at least one night in the provincial district of Mantua. Provision to be applied nationwide. Update as of 10 th September 2009 - During the month of August the regional public health authorities of Emilia Romagna communicated to the National Blood Centre that the results of entomological surveillance indicated a significant degree of positivity of WNV PCR tests carried out on mosquito captures, and a significantly high overall concentration of mosquitoes in several monitored areas of the region. - On 31 st August the second WNV NAT positive blood donation from an asymptomatic blood donor was notified from the Blood Centre of Rovigo, and 3 cases of human neuroinvasive WND were notified interesting respectively two patients resident in the provincial district of Ferrara and one patient resident in the provincial district of Mantua. - On 1 st September 1 case of human neuroinvasive WND in a patient resident in the city of Modena was notified; Modena is located in the Emilia Romagna region, neighboring the provincial districts of Ferrara and Mantua. - Blood donations were not discontinued in the provincial area of Modena as WNV NAT testing was immediately implemented. WNV NAT testing was implemented also on blood donations from donors resident in the neighboring provincial districts of Bologna and Reggio Emilia. - On 3 rd September 1 case of human neuroinvasive WND in a patient resident in the provincial district of Rovigo was notified. - On 5 th September WNV NAT positivity was detected in a solid organ donor resident in the provincial district of Reggio Emilia [information from the Italian National Transplant Centre]. - On 7 th September 1 more case of human neuroinvasive WND was notified in a patient resident in the provincial district of Ferrara. - On 9 th September 2 additional cases of human neuroinvasive WND were notified respectively in a patient resident in the provincial district of Ferrara and in a patient resident in the provincial district of Bologna. - Blood donations were not discontinued in any of the above provincial districts because they were covered by WNV NAT testing. Pagina 2 di 4

- On 31 st August the National Blood Centre indicated the application (nationwide) of 28 day deferral of blood donors having been for at least one night in the provincial districts of Rovigo and Ferrara (the same indication about Mantua had already been issued on 7 th August). - On 1 st September the National Blood Centre indicated the application (nationwide) of 28 day deferral of blood donors having been for at least one night in the provincial district of Modena. - On 10 th September the National Blood Centre has indicated the application (nationwide) of 28 day deferral of blood donors having been for at least one night in the provincial districts of Bologna and Reggio Emilia. - Adequate preventive measures for the prevention of WNV transmission were applied to cord blood and haematopoietic stem cell donations as well. A summary of the above information and a geographical reference map are reported at page 4. Giuliano Grazzini, MD Director Italian National Blood Centre Rome, Italy September, 10 th, 2009 Pagina 3 di 4

SUMMARY as of 10 th September 2009 Provincial Districts WNV NAT testing of blood donations in place WNV NAT positive blood (b) / organ (o) donors Notified cases of human neuroinvasive WND Ferrara 0 4 Rovigo Since 1 st Aug 1 (b) 1 Mantua 1 (b) 1 Modena 0 1 Bologna Since 1 st 3 rd Sept 0 1 Reggio Emilia 1 (o) 0 Provisions to be applied nationwide (blood system) 28 day deferral of blood donors having been for at least one night in these provincial districts Geographical reference Pagina 4 di 4